152 related articles for article (PubMed ID: 34806121)
1. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
Baarsma ME; Vrijlandt A; Ursinus J; Zaaijer HL; Jurriaans S; van Dam AP; Hovius JW
Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):387-393. PubMed ID: 34806121
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the rapid Quidel Sofia Lyme fluorescent immunoassay as a first-tier test in a modified 2-tier testing algorithm for Lyme disease: A comparison with the Zeus ELISA Borrelia VlsE1/pepC10 lgG/IgM assay followed by the Zeus monovalent IgM/IgG confirmatory assay.
Lee-Lewandrowski E; Turbett S; Branda JA; Lewandrowski K
Am J Clin Pathol; 2023 Dec; 160(6):599-602. PubMed ID: 37549102
[TBL] [Abstract][Full Text] [Related]
4. The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study.
Hoeve-Bakker BJA; Jonker M; Brandenburg AH; den Reijer PM; Stelma FF; van Dam AP; van Gorkom T; Kerkhof K; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Apr; 10(2):e0051022. PubMed ID: 35297658
[TBL] [Abstract][Full Text] [Related]
5. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.
Mathiesen MJ; Christiansen M; Hansen K; Holm A; Asbrink E; Theisen M
J Clin Microbiol; 1998 Dec; 36(12):3474-9. PubMed ID: 9817857
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.
Baarsma ME; Ursinus J; Zaaijer HL; Kuiper H; Hovius JW
J Clin Microbiol; 2021 Jun; 59(7):e0320520. PubMed ID: 33883179
[TBL] [Abstract][Full Text] [Related]
8. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
Bacon RM; Biggerstaff BJ; Schriefer ME; Gilmore RD; Philipp MT; Steere AC; Wormser GP; Marques AR; Johnson BJ
J Infect Dis; 2003 Apr; 187(8):1187-99. PubMed ID: 12695997
[TBL] [Abstract][Full Text] [Related]
9. Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Porwancher R; Landsberg L
PLoS One; 2021; 16(9):e0253514. PubMed ID: 34499659
[TBL] [Abstract][Full Text] [Related]
10. Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.
Porwancher RB; Hagerty CG; Fan J; Landsberg L; Johnson BJ; Kopnitsky M; Steere AC; Kulas K; Wong SJ
Clin Vaccine Immunol; 2011 May; 18(5):851-9. PubMed ID: 21367982
[TBL] [Abstract][Full Text] [Related]
11. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
[TBL] [Abstract][Full Text] [Related]
12. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden.
Tjernberg I; Krüger G; Eliasson I
Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):37-42. PubMed ID: 17180348
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays.
Sfeir MM; Meece JK; Theel ES; Granger D; Fritsche TR; Steere AC; Branda JA
J Clin Microbiol; 2022 May; 60(5):e0252821. PubMed ID: 35418241
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
17. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
18. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
19. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
[TBL] [Abstract][Full Text] [Related]
20. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
